CHRNA2 genetic markers associated with galantamine response

Details for Australian Patent Application No. 2004269323 (hide)

Owner Genaissance Pharmaceuticals, Inc.

Inventors Denton, R. Rex; Dain, Bradley; Brain, Carlos; Aerssens, Jeroen; Judson, Richard S.; Athanasiou, Maria; Cohen, Nadine; Reed, Carol R.; Ozdemir, Vural

Agent Blake Dawson Waldron

Pub. Number AU-A-2004269323

PCT Pub. Number WO2005/021796

Priority 60/486,331 11.07.03 US

Filing date 12 July 2004

Wipo publication date 10 March 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/021796 Priority application(s): WO2005/021796

29 November 2007 Assignment before Grant

  Genaissance Pharmaceuticals, Inc. The application has been assigned to PGxHealth, LLC

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004269335-Multi-allelic molecular detection of SARS-associated coronavirus

2004269322-Ion channel assay methods